Definitive Tumor Directed Therapy for Metachronous Oligometastatic HPV-Associated Oropharyngeal Cancer Following Trans-Oral Robotic Surgery
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Lee, D.Y.Wright, C.M.
Shimunov, D.
Carmona, R.
Barsky, A.R.
Sun, L.
Cohen, R.
Bauml, J.
Brody, R.
Basu, D.
Rassekh, C.
O'Malley, B.
Chalian, A.
Newman, J.
Rajasekaran, K.
Weinstein, G.S.
Lukens, J.N.
Lin, A.
Swisher-McClure, S.D.
Date
2021-11Journal
International Journal of Radiation Oncology - Biology - PhysicsPublisher
ElsevierType
Abstract
Metadata
Show full item recordAbstract
Recent landmark trials have suggested a survival benefit to definitive tumor directed therapies (DTDT) for selected patients with metastatic disease for various malignancies. We sought 1) to confirm the prognostic significance of metachronous oligometastatic burden for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) and 2) to evaluate disease outcomes for oligometastatic HPV-associated OPSCC after upfront DTDT versus upfront systemic therapy.Rights/Terms
Copyright © 2021 Published by Elsevier Inc.Identifier to cite or link to this item
http://hdl.handle.net/10713/18469ae974a485f413a2113503eed53cd6c53
10.1016/j.ijrobp.2021.07.1165